Search

everythinglearnresearchcommunity

for

Search:↓

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

Multiphoton microscopy can effectively assess breast cancer treatment responses without labels.

Cancer treatments often cause hair loss, and more research is needed to prevent and treat it.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Scalp cooling reduces hair loss and improves quality of life during chemotherapy.

Scalp cooling is cost-effective for reducing hair loss from chemotherapy and should be covered by insurance.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Fasting may reduce chemotherapy side effects.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Nutritional education reduces chemotherapy side effects and improves health in breast cancer patients.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

Scalp cooling effectively prevents hair loss during chemotherapy in most cases.

People undergoing chemotherapy need better support and information to cope with hair loss.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.